Engineered Nanoparticulate Drug Delivery Systems: The Next Frontier for Oral Administration?

被引:39
作者
Diab, Roudayna [1 ]
Jaafar-Maalej, Chiraz [2 ]
Fessi, Hatem [2 ]
Maincent, Philippe [1 ]
机构
[1] Univ Lorraine, Fac Pharm, CITHEFOR EA 3452, Pharmaceut Technol Grp, F-54001 Nancy, France
[2] Univ Lyon, ISPBL Fac Pharm, UMR CNRS 5007, Pharmaceut Technol Grp,LAGEP, F-69622 Villeurbanne, France
来源
AAPS JOURNAL | 2012年 / 14卷 / 04期
关键词
biodegradable; nanoparticles; natural; oral; polymer; SOLID LIPID NANOPARTICLES; IN-VIVO EVALUATION; LOADED POLYMERIC NANOPARTICLES; POORLY ABSORBABLE DRUGS; MODIFIED SILICA NANOPARTICLES; CHITOSAN NANOPARTICLES; GOLD NANOPARTICLES; ABSORPTION ENHANCERS; INSULIN DELIVERY; GLIADIN NANOPARTICLES;
D O I
10.1208/s12248-012-9377-y
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For the past few decades, there has been a considerable research interest in the area of oral drug delivery using nanoparticle (NP) delivery systems as carriers. Oral NPs have been used as a physical approach to improve the solubility and the stability of active pharmaceutical ingredients (APIs) in the gastrointestinal juices, to enhance the intestinal permeability of drugs, to sustain and to control the release of encapsulated APIs allowing the dosing frequency to be reduced, and finally, to achieve both local and systemic drug targeting. Numerous materials have been used in the formulation of oral NPs leading to different nanoparticulate platforms. In this paper, we review various aspects of the formulation and the characterization of polymeric, lipid, and inorganic NPs. Special attention will be dedicated to their performance in the oral delivery of drug molecules and therapeutic genes.
引用
收藏
页码:688 / 702
页数:15
相关论文
共 111 条
  • [11] Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles
    Borges, Olga
    Tavares, Joana
    de Sousa, Adriano
    Borchard, Gerrit
    Junginger, Hans E.
    Cordeiro-da-Silva, Anabela
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 32 (4-5) : 278 - 290
  • [12] Chitosan nanoparticles for oral drug and gene delivery
    Bowman, Katherine
    Leong, Kam W.
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2006, 1 (02): : 117 - 128
  • [13] Apical membrane receptors on intestinal M cells: potential targets for vaccine delivery
    Brayden, DJ
    Baird, AW
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (06) : 721 - 726
  • [14] N-Trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery
    Cao, Jinna
    Sun, Jukui
    Wang, Xiaoyu
    Li, Xinran
    Deng, Yingjie
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2009, 35 (11) : 1339 - 1347
  • [15] Cystatin incorporated in poly(lactide-co-glycolide) nanoparticles: development and fundamental studies on preservation of its activity
    Cegnar, M
    Kos, J
    Kristl, J
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 22 (05) : 357 - 364
  • [16] In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line
    Chang, Jenq-Sheng
    Chang, Ke Liang B.
    Hwang, Deng-Fwu
    Kong, Zwe-Ling
    [J]. ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2007, 41 (06) : 2064 - 2068
  • [17] Inclusion of ibuprofen in mesoporous templated silica:: drug loading and release property
    Charnay, C
    Bégu, S
    Tourné-Péteilh, C
    Nicole, L
    Lerner, DA
    Devoisselle, JM
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (03) : 533 - 540
  • [18] Biodegradable poly(ε-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen
    Chawla, JS
    Amiji, MM
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 249 (1-2) : 127 - 138
  • [19] Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice
    Chew, JL
    Wolfowicz, CB
    Mao, HQ
    Leong, KW
    Chua, KY
    [J]. VACCINE, 2003, 21 (21-22) : 2720 - 2729
  • [20] Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity
    Connor, EE
    Mwamuka, J
    Gole, A
    Murphy, CJ
    Wyatt, MD
    [J]. SMALL, 2005, 1 (03) : 325 - 327